Birrell SN, Bentel JM, Hickey D, Riciardelli C, Weger MA, Horsfall DI, et al. Androgens induce divergent proliferative response in human breast cell lines. J Steroid Biochem Mol Biol. 1995;52:459–67.CrossrefGoogle Scholar
Isakson E, von Schoultz E, Odlind V, Söderqvist, G, Csemiczky G, Carlström K, et al. Effects of oral contraceptives on breast epithelial proliferation. Breast Cancer Res Treat. 2001;65:163–9.CrossrefPubMedGoogle Scholar
Hofling M, Lundström E, Azavedo E, Svane G, Lindén-Hirschberg A, von Schoultz B. Testosterone addition during postmenopausal therapy: effects on mammographic breast density. Climacteric. 2007;10:155–63.PubMedCrossrefGoogle Scholar
Hofling M, Löfgren L, von Schoultz E, Carlström K, Söderqvist G. Associations between serum testosterone levels, cell proliferation and progesterone receptor content in normal and malignant breast tissue. Gynecol Endocrinol. 2008;24:405–10.Web of SciencePubMedCrossrefGoogle Scholar
McCulloch DR, Akl P, Samaratunga H, Herington AC, Odorico DM. Expression of the disintegrin metallo-protease, ADAM-10, in prostate cancer and its regulation by dihydrotestosterone, insulin-like growth factor I and epidermal growth factor in the prostate cancer cell model LNCaP. Clin Cancer Res. 2004;10:314–23.CrossrefGoogle Scholar
Edwall L, Carlström K, Fianu-Jonasson A. Endocrine status and markers of collagen synthesis and degradation in serum and urogenital tissue from women with and without stress urinary incontinence. Neurourol Urodynam. 2007;26:410–5.CrossrefWeb of ScienceGoogle Scholar
Davies ME, Gumucio JP, Sugg KB, Bedi A, Mendias CL. MMP inhibition as a potential method to augment the healing of skeletal muscle and tendon extracellular matrix. J Appl Physiol. 2013;115:884–91.Web of ScienceCrossrefPubMedGoogle Scholar
Lundström E, Conner P, Naessén S, Löfgren L, Carlström K, Söderqvist G. Estrone a partial estradiol antagonist in the normal breast. Gynecol Endocrinol. 2015;31:747–9.Web of ScienceCrossrefPubMedGoogle Scholar
Lundström E, Christow A, Kersemaekers W, Svane G, Azavedo E, Söderqvist G, et al. Effects of tibolone and continuous combined hormone replacement therapy on mammographic breast density. Am J Obstet Gynecol. 2002;186:717–22.CrossrefPubMedGoogle Scholar
Lundström E, Lindén Hirschberg A, Söderqvist G. Digitized assessment of mammographic breast density – effect of continuous combined therapy, tibolone and black cohosh compared to placebo. Maturitas. 2011;70:361–4.CrossrefGoogle Scholar
Lundström E, Söderqvist G, Svane G, Azawedo E, Olovsson M, von Schoultz E, et al. Digitized assessment of mammographic breast density in patients who received low dose intrauterine levo-norgestrel in continuous combination with oral estradiol valerate: a pilot study. Fertil Steril. 2006;85:989–95.CrossrefGoogle Scholar
Hofling M, Carlström K, Svane G, Azavedo E, Klosterboer H, von Schoultz B. Different effects of tibolone and continuous combined estrogen plus progestogen hormone therapy on sex hormone-binding globulin and free testosterone levels – an association with mammographic density. Gynecol Endocrinol. 2005;20:110–5.PubMedCrossrefGoogle Scholar
Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography–mass spectrometry in sera from 116 men, women and children. Clin Chem. 2003;49:1381–95.PubMedCrossrefGoogle Scholar
Carlström K, Brody S, Lunell NO, Lagrelius A, Möllerström G, Pousette A, et al. Dehydroepiandrosterone sulfate and dehydroepiandrosterone in serum: age and sex-related differences. Maturitas. 1988;10:297–306.CrossrefGoogle Scholar
Eklund E, Berglund B, Labrie F, Carlström K, Ekström L, Hirschberg AL. Serum androgen profile and physical performance in women Olympic athletes. Br J Sports Med. 2017;51:1301–8.Web of SciencePubMedCrossrefGoogle Scholar
Södergård R, Bäckström T, Shanbhag V, Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17β to plasma proteins at body temperature. J Steroid Biochem. 1982;16:801–10.PubMedCrossrefGoogle Scholar
Naessen T, Sjogren U, Bergquist J, Larsson M, Lind L, Kushnir MM. Endogenous steroids measured by high-specificity liquid chromatography-tandem mass spectrometry and prevalent cardiovascular disease in 70-year-old men and women. J Clin Endocrinol Metab. 2010;95:1889–97.Web of SciencePubMedCrossrefGoogle Scholar
Zumoff BV, Bradlow HL. Sex difference in the metabolism of dehydroisoandrosterone sulfate. JCEM. 1980;51:334–6.Google Scholar
Longcope C. Dehydroepiandrosterone metabolism. J Endocrinol. 1996;150:125–7.Google Scholar
Montt-Guevara MM, Shortrede JE, Giretti MS, Giannini A, Mannella P, Russo E, et al. Androgens regulate T47D cells motility and invasion through actin cytoskeleton remodeling. Front Endocrinol. 2016;7:136.Web of ScienceGoogle Scholar
Tamimi RM, Hankinson SE, Chen WY, Rosner B, Colditz GA. Combined estrogen and testosterone use and risk of breast cancer in postmenopausal women. Arch Intern Med. 2006;166:1483–9.PubMedCrossrefGoogle Scholar
Glaser RL, Dimitrakakis C. Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study. Maturitas. 2013;76:342–9.PubMedCrossrefWeb of ScienceGoogle Scholar
About the article
Published Online: 2018-08-25
Research funding: This study was supported by grants from the Swedish Cancer Society, the Swedish Research Council (project No. 5982), the Karolinska Institutet Research Funds and NV ORGANON, Oss, The Netherlands.
Conflict of interest: All authors declare no conflict of interest.
Informed consent: Informed consent has been obtained from all individuals included into the study.
Ethical approval: The research results related to human use complied with all the relevant national regulations and institutional policies, was performed in accordance to the tenets of the Helsinki Declaration and has been approved by the local institutional review board.